(Q51424093)
Statements
1 reference
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. (English)
1 reference
1 reference
Stina Söderlund
1 reference
Lisa Christiansson
1 reference
Inger Persson
1 reference
Henrik Hjorth-Hansen
1 reference
Johan Richter
1 reference
Bengt Simonsson
1 reference
Ulla Olsson-Strömberg
1 reference
Angelica Loskog
1 reference
27 September 2016
1 reference
1 reference
50
1 reference
95-103
1 reference
Identifiers
1 reference